North American white mitochondrial haplogroups in prostate and renal cancer

Lyra M. Booker, Geoffrey M. Habermacher, Benjamin C. Jessie, Qi Carrie Sun, Amanda K. Baumann, Mahul Amin, So Dug Lim, Carina Fernandez-Golarz, Robert H. Lyles, Michael D. Brown, Fray F. Marshall, John A. Petros

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Purpose: While the mitochondrion is known to be a key mediator of apoptosis, there has been little inquiry into the inheritance pattern of mitochondria in patients with cancer. We compared the mtDNA haplotype in patients with prostate and renal cancer to that in controls to determine if there is an association between mitochondrial genotype and cancer. Materials and Methods: Haplotyping was performed using polymerase chain reaction/digest identification of key polymorphic sites in the mitochondrial genome. A total of 121 and 221 white men with renal and prostate cancer, respectively, were identified following pathological confirmation of cancer, while 246 white controls were selected randomly from a bank of cadaveric organ donor DNA. Statistical analysis was performed and ORs were calculated. Results: Mitochondrial haplogroup U was a highly significant risk factor for prostate and renal cancer vs controls (16.74% and 20.66% vs 9.35%, Fisher's exact test p = 0.019 and 0.005, respectively). The association remained statistically significant in renal cancer even after Bonferroni adjustment for multiple comparisons. Haplogroup U carried an OR of 1.95 for prostate cancer and an OR of 2.52 for renal cancer. Conclusions: The inheritance of mitochondrial haplogroup U is associated with an approximately 2-fold increased risk of prostate cancer and 2.5-fold increased risk of renal cancer in white North American individuals. Therefore, individuals with this mitochondrial haplotype are in a high risk group. Because mitochondrial haplogroup U is found in 9.35% of the white United States population, there are more than 20 million individuals in this high risk group.

Original languageEnglish (US)
Pages (from-to)468-473
Number of pages6
JournalJournal of Urology
Volume175
Issue number2
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Kidney Neoplasms
Prostatic Neoplasms
Haplotypes
Mitochondria
Inheritance Patterns
Neoplasms
Mitochondrial Genome
Mitochondrial Genes
Mitochondrial DNA
Genotype
Tissue Donors
Apoptosis
Polymerase Chain Reaction
DNA
Population

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Booker, L. M., Habermacher, G. M., Jessie, B. C., Sun, Q. C., Baumann, A. K., Amin, M., ... Petros, J. A. (2006). North American white mitochondrial haplogroups in prostate and renal cancer. Journal of Urology, 175(2), 468-473. https://doi.org/10.1016/S0022-5347(05)00163-1

North American white mitochondrial haplogroups in prostate and renal cancer. / Booker, Lyra M.; Habermacher, Geoffrey M.; Jessie, Benjamin C.; Sun, Qi Carrie; Baumann, Amanda K.; Amin, Mahul; Lim, So Dug; Fernandez-Golarz, Carina; Lyles, Robert H.; Brown, Michael D.; Marshall, Fray F.; Petros, John A.

In: Journal of Urology, Vol. 175, No. 2, 01.01.2006, p. 468-473.

Research output: Contribution to journalArticle

Booker, LM, Habermacher, GM, Jessie, BC, Sun, QC, Baumann, AK, Amin, M, Lim, SD, Fernandez-Golarz, C, Lyles, RH, Brown, MD, Marshall, FF & Petros, JA 2006, 'North American white mitochondrial haplogroups in prostate and renal cancer', Journal of Urology, vol. 175, no. 2, pp. 468-473. https://doi.org/10.1016/S0022-5347(05)00163-1
Booker, Lyra M. ; Habermacher, Geoffrey M. ; Jessie, Benjamin C. ; Sun, Qi Carrie ; Baumann, Amanda K. ; Amin, Mahul ; Lim, So Dug ; Fernandez-Golarz, Carina ; Lyles, Robert H. ; Brown, Michael D. ; Marshall, Fray F. ; Petros, John A. / North American white mitochondrial haplogroups in prostate and renal cancer. In: Journal of Urology. 2006 ; Vol. 175, No. 2. pp. 468-473.
@article{817a52dac2cc46e5bf772ac6b537f7ba,
title = "North American white mitochondrial haplogroups in prostate and renal cancer",
abstract = "Purpose: While the mitochondrion is known to be a key mediator of apoptosis, there has been little inquiry into the inheritance pattern of mitochondria in patients with cancer. We compared the mtDNA haplotype in patients with prostate and renal cancer to that in controls to determine if there is an association between mitochondrial genotype and cancer. Materials and Methods: Haplotyping was performed using polymerase chain reaction/digest identification of key polymorphic sites in the mitochondrial genome. A total of 121 and 221 white men with renal and prostate cancer, respectively, were identified following pathological confirmation of cancer, while 246 white controls were selected randomly from a bank of cadaveric organ donor DNA. Statistical analysis was performed and ORs were calculated. Results: Mitochondrial haplogroup U was a highly significant risk factor for prostate and renal cancer vs controls (16.74{\%} and 20.66{\%} vs 9.35{\%}, Fisher's exact test p = 0.019 and 0.005, respectively). The association remained statistically significant in renal cancer even after Bonferroni adjustment for multiple comparisons. Haplogroup U carried an OR of 1.95 for prostate cancer and an OR of 2.52 for renal cancer. Conclusions: The inheritance of mitochondrial haplogroup U is associated with an approximately 2-fold increased risk of prostate cancer and 2.5-fold increased risk of renal cancer in white North American individuals. Therefore, individuals with this mitochondrial haplotype are in a high risk group. Because mitochondrial haplogroup U is found in 9.35{\%} of the white United States population, there are more than 20 million individuals in this high risk group.",
author = "Booker, {Lyra M.} and Habermacher, {Geoffrey M.} and Jessie, {Benjamin C.} and Sun, {Qi Carrie} and Baumann, {Amanda K.} and Mahul Amin and Lim, {So Dug} and Carina Fernandez-Golarz and Lyles, {Robert H.} and Brown, {Michael D.} and Marshall, {Fray F.} and Petros, {John A.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/S0022-5347(05)00163-1",
language = "English (US)",
volume = "175",
pages = "468--473",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - North American white mitochondrial haplogroups in prostate and renal cancer

AU - Booker, Lyra M.

AU - Habermacher, Geoffrey M.

AU - Jessie, Benjamin C.

AU - Sun, Qi Carrie

AU - Baumann, Amanda K.

AU - Amin, Mahul

AU - Lim, So Dug

AU - Fernandez-Golarz, Carina

AU - Lyles, Robert H.

AU - Brown, Michael D.

AU - Marshall, Fray F.

AU - Petros, John A.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Purpose: While the mitochondrion is known to be a key mediator of apoptosis, there has been little inquiry into the inheritance pattern of mitochondria in patients with cancer. We compared the mtDNA haplotype in patients with prostate and renal cancer to that in controls to determine if there is an association between mitochondrial genotype and cancer. Materials and Methods: Haplotyping was performed using polymerase chain reaction/digest identification of key polymorphic sites in the mitochondrial genome. A total of 121 and 221 white men with renal and prostate cancer, respectively, were identified following pathological confirmation of cancer, while 246 white controls were selected randomly from a bank of cadaveric organ donor DNA. Statistical analysis was performed and ORs were calculated. Results: Mitochondrial haplogroup U was a highly significant risk factor for prostate and renal cancer vs controls (16.74% and 20.66% vs 9.35%, Fisher's exact test p = 0.019 and 0.005, respectively). The association remained statistically significant in renal cancer even after Bonferroni adjustment for multiple comparisons. Haplogroup U carried an OR of 1.95 for prostate cancer and an OR of 2.52 for renal cancer. Conclusions: The inheritance of mitochondrial haplogroup U is associated with an approximately 2-fold increased risk of prostate cancer and 2.5-fold increased risk of renal cancer in white North American individuals. Therefore, individuals with this mitochondrial haplotype are in a high risk group. Because mitochondrial haplogroup U is found in 9.35% of the white United States population, there are more than 20 million individuals in this high risk group.

AB - Purpose: While the mitochondrion is known to be a key mediator of apoptosis, there has been little inquiry into the inheritance pattern of mitochondria in patients with cancer. We compared the mtDNA haplotype in patients with prostate and renal cancer to that in controls to determine if there is an association between mitochondrial genotype and cancer. Materials and Methods: Haplotyping was performed using polymerase chain reaction/digest identification of key polymorphic sites in the mitochondrial genome. A total of 121 and 221 white men with renal and prostate cancer, respectively, were identified following pathological confirmation of cancer, while 246 white controls were selected randomly from a bank of cadaveric organ donor DNA. Statistical analysis was performed and ORs were calculated. Results: Mitochondrial haplogroup U was a highly significant risk factor for prostate and renal cancer vs controls (16.74% and 20.66% vs 9.35%, Fisher's exact test p = 0.019 and 0.005, respectively). The association remained statistically significant in renal cancer even after Bonferroni adjustment for multiple comparisons. Haplogroup U carried an OR of 1.95 for prostate cancer and an OR of 2.52 for renal cancer. Conclusions: The inheritance of mitochondrial haplogroup U is associated with an approximately 2-fold increased risk of prostate cancer and 2.5-fold increased risk of renal cancer in white North American individuals. Therefore, individuals with this mitochondrial haplotype are in a high risk group. Because mitochondrial haplogroup U is found in 9.35% of the white United States population, there are more than 20 million individuals in this high risk group.

UR - http://www.scopus.com/inward/record.url?scp=30344471873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30344471873&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(05)00163-1

DO - 10.1016/S0022-5347(05)00163-1

M3 - Article

VL - 175

SP - 468

EP - 473

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -